Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Search for new tuberculosis vaccines].

B Gicquel1

  • 1Unité de génétique Mycobactérienne, Institut Pasteur, Paris.

Bulletin De L'Academie Nationale De Medecine
|January 6, 2000
PubMed
Summary

Developing new tuberculosis vaccines is crucial as the current BCG vaccine shows variable efficacy. Researchers are exploring protein antigens and attenuated Mycobacterium tuberculosis strains, like the purC mutant, for improved protection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuberculosis trends in a hot-spot region in Paris, France.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author

Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2015
Same author

Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2012
Same author

Gene Replacement and Transposon Delivery Using the Negative Selection Marker sacB.

Methods in molecular medicine·2011
Same author

Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2010
Same author

T-cell responses and in vivo cytotoxicity in the target organ and the regional lymphoid tissue during airborne infection with the virulent Mycobacterium tuberculosis MT103 and its lipid mutant fadD26.

Scandinavian journal of immunology·2009

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Context:

  • Cellular immune responses are critical for controlling tuberculosis (TB).
  • The Bacillus Calmette-Guérin (BCG) vaccine protects infants against severe TB but has variable efficacy in adults.
  • Existing TB vaccines necessitate the development of novel strategies.

Purpose:

  • To review current research on cellular immunity and vaccine development for tuberculosis.
  • To explore novel vaccine candidates, including protein antigens and attenuated Mycobacterium tuberculosis strains.
  • To assess the potential of genetic modifications in M. tuberculosis for vaccine development.

Summary:

  • Studies highlight the importance of cellular immunity in tuberculosis control.
  • Recombinant protein antigens and DNA vaccines from Mycobacterium tuberculosis show promise.
  • Attenuated M. tuberculosis strains, such as a purC mutant, demonstrate significant protection in animal models.
  • Targeted genetic inactivation of virulence factors in M. tuberculosis is a key strategy for developing live attenuated vaccines.

Impact:

  • New vaccine strategies may improve protection against adult forms of tuberculosis.
  • Understanding genetic virulence factors aids in creating safer and more effective TB vaccines.
  • Future vaccination protocols could involve multi-mutated attenuated strains and novel antigen delivery systems.

Related Experiment Videos